Resumen de The cancer defense.
The article focuses on immunotherapy treatment for aggressive skin and lung cancers which have caused apparent cancer remission. It comments on the monoclonal antibody rituximab which signals T cells to attack the B cell protein CD20 found on normal and cancerous B cells and the development of an alternative drug that targets the B cell protein CD19 but can also cause cytokine release syndrome. It talks about research of the immunotherapy ipilimumab for treating solid tumors in melanoma.
